349 related articles for article (PubMed ID: 34207696)
1. HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.
Mathieu NA; Paparisto E; Barr SD; Spratt DE
Viruses; 2021 Jun; 13(6):. PubMed ID: 34207696
[TBL] [Abstract][Full Text] [Related]
2. Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).
Gold IM; Reis N; Glaser F; Glickman MH
Semin Cell Dev Biol; 2022 Dec; 132():16-26. PubMed ID: 35764457
[TBL] [Abstract][Full Text] [Related]
3. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
[TBL] [Abstract][Full Text] [Related]
4. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells.
Oudshoorn D; van Boheemen S; Sánchez-Aparicio MT; Rajsbaum R; García-Sastre A; Versteeg GA
PLoS One; 2012; 7(1):e29870. PubMed ID: 22272257
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase.
Domingues P; Bamford CGG; Boutell C; McLauchlan J
J Gen Virol; 2015 Nov; 96(11):3236-3242. PubMed ID: 26361997
[TBL] [Abstract][Full Text] [Related]
6. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15.
Durfee LA; Lyon N; Seo K; Huibregtse JM
Mol Cell; 2010 Jun; 38(5):722-32. PubMed ID: 20542004
[TBL] [Abstract][Full Text] [Related]
7. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.
Wong JJ; Pung YF; Sze NS; Chin KC
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10735-40. PubMed ID: 16815975
[TBL] [Abstract][Full Text] [Related]
8. HERC5 E3 ligase mediates ISGylation of hepatitis B virus X protein to promote viral replication.
Bawono RG; Abe T; Qu M; Kuroki D; Deng L; Matsui C; Ryo A; Suzuki T; Matsuura Y; Sugiyama M; Mizokami M; Shimotohno K; Shoji I
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34661519
[TBL] [Abstract][Full Text] [Related]
9. Identification and Herc5-mediated ISGylation of novel target proteins.
Takeuchi T; Inoue S; Yokosawa H
Biochem Biophys Res Commun; 2006 Sep; 348(2):473-7. PubMed ID: 16884686
[TBL] [Abstract][Full Text] [Related]
10. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein.
Tang Y; Zhong G; Zhu L; Liu X; Shan Y; Feng H; Bu Z; Chen H; Wang C
J Immunol; 2010 May; 184(10):5777-90. PubMed ID: 20385878
[TBL] [Abstract][Full Text] [Related]
11. Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators.
Kim YJ; Kim ET; Kim YE; Lee MK; Kwon KM; Kim KI; Stamminger T; Ahn JH
PLoS Pathog; 2016 Aug; 12(8):e1005850. PubMed ID: 27564865
[TBL] [Abstract][Full Text] [Related]
12. The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN.
Du X; Sheng J; Chen Y; He S; Yang Y; Huang Y; Fu Y; Lie L; Han Z; Zhu B; Liu H; Wen Q; Zhou X; Zhou C; Hu S; Ma L
Sci Signal; 2023 Jun; 16(788):eabm1756. PubMed ID: 37279284
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.
Jacobs SR; Stopford CM; West JA; Bennett CL; Giffin L; Damania B
J Virol; 2015 Nov; 89(22):11572-83. PubMed ID: 26355087
[TBL] [Abstract][Full Text] [Related]
14. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells.
Dastur A; Beaudenon S; Kelley M; Krug RM; Huibregtse JM
J Biol Chem; 2006 Feb; 281(7):4334-8. PubMed ID: 16407192
[TBL] [Abstract][Full Text] [Related]
15. Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag.
Woods MW; Kelly JN; Hattlmann CJ; Tong JG; Xu LS; Coleman MD; Quest GR; Smiley JR; Barr SD
Retrovirology; 2011 Nov; 8():95. PubMed ID: 22093708
[TBL] [Abstract][Full Text] [Related]
16. The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
Chen L; Li S; McGilvray I
Int J Biochem Cell Biol; 2011 Oct; 43(10):1427-31. PubMed ID: 21704181
[TBL] [Abstract][Full Text] [Related]
17. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification.
Shi HX; Yang K; Liu X; Liu XY; Wei B; Shan YF; Zhu LH; Wang C
Mol Cell Biol; 2010 May; 30(10):2424-36. PubMed ID: 20308324
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export.
Woods MW; Tong JG; Tom SK; Szabo PA; Cavanagh PC; Dikeakos JD; Haeryfar SM; Barr SD
Retrovirology; 2014 Apr; 11():27. PubMed ID: 24693865
[TBL] [Abstract][Full Text] [Related]
19. [Advances in ubiquitin-like protein ISG15-mediated anti-viral response].
Zhu ZX; Wei JC; Shi ZX; Wu KB; Ma ZY
Bing Du Xue Bao; 2012 Jan; 28(1):78-83. PubMed ID: 22416355
[TBL] [Abstract][Full Text] [Related]
20. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein.
Versteeg GA; Hale BG; van Boheemen S; Wolff T; Lenschow DJ; García-Sastre A
J Virol; 2010 May; 84(10):5423-30. PubMed ID: 20219937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]